![Frank Thomas](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Frank Thomas
Ordförande på
SPERO THERAPEUTICS, INC.
Förmögenhet: 118 240 $ per 2026-08-31
Profil
Frank E.
Thomas is Chairman at Spero Therapeutics, Inc. since 2025.
Holds director positions at Orchard Therapeutics North America and Larimar Therapeutics, Inc. since 2014.
Serves as President & Chief Operating Officer at Orchard Therapeutics (Europe) Ltd. since 2020 and at Orchard Therapeutics Plc since 2018.
Former roles include President, Chief Executive Officer & Director at Critical Therapeutics, Inc. from 2006 to 2008; Controller & Finance Director at Mechanical Dynamics, Inc. from 1997 to 2000; Independent Director at Zafgen, Inc.; Director at Massachusetts Biotechnology Council from 2007 to 2015; Chief Financial Officer & VP-Investor Relations at Esperion Therapeutics, Inc. from 2000 to 2004; Chief Operating Officer & Senior Vice President at Molecular Biometrics, Inc. from 2010 to 2011; Principal at Arthur Andersen LLP from 1992 to 2000; and President & Chief Operating Officer at AMAG Pharmaceuticals, Inc. from 2016 to 2017.
Education includes undergraduate studies at the University of Michigan.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
SPERO THERAPEUTICS, INC. 0,13 % | 2026-06-23 | 75 000 ( 0,13 % ) | 91 500 $ | 2026-08-31 |
| 2026-05-19 | 7 000 ( 0,01 % ) | 26 740 $ | 2026-08-31 |
Aktiva positioner av Frank Thomas
| Företag | Position | Start |
|---|---|---|
| SPERO THERAPEUTICS, INC. | Ordförande | 2025-01-10 |
| ORCHARD THERAPEUTICS PLC | President | 2020-03-18 |
| LARIMAR THERAPEUTICS, INC. | Direktör/Styrelseledamot | 2014-01-01 |
Orchard Therapeutics (Europe) Ltd.
 Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Researches on transformative gene therapies | President | 2020-03-17 |
Orchard Therapeutics North America
 Orchard Therapeutics North America BiotechnologyHealth Technology Provides biotechnology research services | Direktör/Styrelseledamot | - |
Tidigare kända positioner av Frank Thomas
| Företag | Position | Slut |
|---|---|---|
| AMAG PHARMACEUTICALS, INC. | Verkställande Direktör | 2012-05-14 |
Massachusetts Biotechnology Council
 Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Operates as an association of biotechnology companies | Direktör/Styrelseledamot | 2015-01-01 |
Molecular Biometrics, Inc.
 Molecular Biometrics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops analytical methodologies for molecular diagnostic | Finansdirektör/CFO | 2010-01-18 |
Critical Therapeutics, Inc.
 Critical Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes products for respiratory, inflammatory and critical care diseases | Verkställande Direktör | 2008-03-31 |
| ░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Frank Thomass utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
79
Första gradens relationer
14
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 14 |
|---|---|
Mechanical Dynamics, Inc.
 Mechanical Dynamics, Inc. Information Technology ServicesTechnology Services Develops, markets, and supports virtual prototyping solutions | Technology Services |
Esperion Therapeutics, Inc.
 Esperion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and discovers biopharmaceutical products | Health Technology |
Critical Therapeutics, Inc.
Critical Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes products for respiratory, inflammatory and critical care diseases | Health Technology |
Molecular Biometrics, Inc.
Molecular Biometrics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops analytical methodologies for molecular diagnostic | Commercial Services |
Zafgen, Inc.
 Zafgen, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company | Health Technology |
Arthur Andersen LLP
 Arthur Andersen LLP Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Commercial Services |
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Biotechnology Council
Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Operates as an association of biotechnology companies | Commercial Services |
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products for maternal & women health, anemia management and cancer supportive care | Health Technology |
Spero Therapeutics, Inc.
 Spero Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of bacterial infections | Health Technology |
Orchard Therapeutics (Europe) Ltd.
Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Researches on transformative gene therapies | Health Technology |
Orchard Therapeutics Plc
 Orchard Therapeutics Plc BiotechnologyHealth Technology Engages in research and advancements of gene therapy to develop potential cures for genetic & other severe diseases | Health Technology |
Orchard Therapeutics North America
Orchard Therapeutics North America BiotechnologyHealth Technology Provides biotechnology research services | Health Technology |
Larimar Therapeutics, Inc.
 Larimar Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company focused on developing treatments for complex rare diseases | Health Technology |
